UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 175 filers reported holding UNIQURE NV in Q3 2021. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $5,705,000 | +3.9% | 178,216 | 0.0% | 0.02% | +4.3% |
| Q2 2021 | $5,489,000 | +1268.8% | 178,216 | +1538.5% | 0.02% | +666.7% |
| Q3 2020 | $401,000 | -96.7% | 10,877 | -96.0% | 0.00% | -96.3% |
| Q2 2020 | $12,265,000 | +1.8% | 272,174 | +7.2% | 0.08% | -11.0% |
| Q1 2020 | $12,048,000 | -51.9% | 253,918 | -27.4% | 0.09% | -24.8% |
| Q4 2019 | $25,061,000 | +192.3% | 349,722 | +60.5% | 0.12% | +146.9% |
| Q3 2019 | $8,575,000 | +1079.5% | 217,861 | +763.3% | 0.05% | +600.0% |
| Q4 2018 | $727,000 | +210.7% | 25,235 | +307.8% | 0.01% | +600.0% |
| Q2 2018 | $234,000 | – | 6,188 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 841,471 | $15,786,000 | 5.69% |
| Nantahala Capital Management | 2,901,929 | $54,440,000 | 3.52% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 544,500 | $10,209,000 | 3.27% |
| 683 Capital Management, LLC | 1,373,600 | $25,768,000 | 1.99% |
| PFM Health Sciences, LP | 2,393,311 | $44,899,000 | 1.62% |
| Integral Health Asset Management, LLC | 433,000 | $8,123,000 | 1.58% |
| Privium Fund Management B.V. | 238,998 | $4,283,000 | 1.56% |
| Nantahala Capital Management | 1,000,000 | $18,760,000 | 1.21% |
| Henry James International Management Inc. | 89,469 | $1,678,000 | 0.94% |
| Altium Capital Management LP | 105,000 | $1,970,000 | 0.72% |